ArticleEndocrine2025
Evaluation of corticoresistance in patients with thyroid eye disease and use of rituximab as a second-line treatment.
Klara Pekarova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it